Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Vaccine [Vaccine] NLMUID: 8406899"" wg kryterium: JN


Tytuł :
Identification of potent epitopes on hexon capsid protein and their evaluation as vaccine candidates against infections caused by members of Adenoviridae family.
Autorzy :
Tufail S; Drug Discovery and Structural Biology group, Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering (NIBGE), Faisalabad, Pakistan; Pakistan Institute of Engineering and Applied Sciences (PIEAS), P.O. Nilore, Islamabad, Pakistan.
Shah MA; Drug Discovery and Structural Biology group, Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering (NIBGE), Faisalabad, Pakistan; Pakistan Institute of Engineering and Applied Sciences (PIEAS), P.O. Nilore, Islamabad, Pakistan.
Zafar M; Drug Discovery and Structural Biology group, Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering (NIBGE), Faisalabad, Pakistan; Pakistan Institute of Engineering and Applied Sciences (PIEAS), P.O. Nilore, Islamabad, Pakistan.
Asif TA; Drug Discovery and Structural Biology group, Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering (NIBGE), Faisalabad, Pakistan; Pakistan Institute of Engineering and Applied Sciences (PIEAS), P.O. Nilore, Islamabad, Pakistan.
Shehzad A; Drug Discovery and Structural Biology group, Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering (NIBGE), Faisalabad, Pakistan; Pakistan Institute of Engineering and Applied Sciences (PIEAS), P.O. Nilore, Islamabad, Pakistan.
Shah MS; Vaccine Development group, Animal Sciences Division, Nuclear Institute for Agriculture and Biology (NIAB), Faisalabad, Pakistan.
Habib M; Vaccine Development group, Animal Sciences Division, Nuclear Institute for Agriculture and Biology (NIAB), Faisalabad, Pakistan.
Saleemi MK; Department of Pathology, Faculty of Veterinary Science, University of Agriculture, Faisalabad 38040, Pakistan.
Muddassar M; Department of Biosciences, COMSATS-University Islamabad, Park Road, Islamabad, Pakistan.
Mirza O; Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Iqbal M; Drug Discovery and Structural Biology group, Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering (NIBGE), Faisalabad, Pakistan; Pakistan Institute of Engineering and Applied Sciences (PIEAS), P.O. Nilore, Islamabad, Pakistan.
Rahman M; Drug Discovery and Structural Biology group, Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering (NIBGE), Faisalabad, Pakistan; Pakistan Institute of Engineering and Applied Sciences (PIEAS), P.O. Nilore, Islamabad, Pakistan; School of Biological Sciences, University of the Punjab, Lahore, Pakistan. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Jun 16; Vol. 39 (27), pp. 3560-3564. Date of Electronic Publication: 2021 May 22.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Vaccine acceptability, uptake and completion amongst men who have sex with men: A systematic review, meta-analysis and theoretical framework.
Autorzy :
Nadarzynski T; The University of Westminster, London, United Kingdom. Electronic address: .
Frost M; The University of Southampton, Southampton, United Kingdom.
Miller D; The University of Westminster, London, United Kingdom.
Wheldon CW; Temple University, Philadelphia, PA, USA.
Wiernik BM; The University of South Florida, Tampa, USA.
Zou H; Sun Yat-sen University, School of Public Health, Shenzhen, China.
Richardson D; Brighton & Sussex University Hospitals NHS Trust, Brighton; Brighton & Sussex Medical School, University of Sussex, Falmer, United Kingdom.
Marlow LAV; Cancer Prevention Group, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom.
Smith H; Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, Singapore.
Jones CJ; University of Surrey, Guildford, United Kingdom.
Llewellyn C; Brighton & Sussex Medical School, University of Sussex, Falmer, United Kingdom.
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Jun 16; Vol. 39 (27), pp. 3565-3581. Date of Electronic Publication: 2021 May 24.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Incidence of pediatric inflammatory bowel disease within the Vaccine Safety Datalink network and evaluation of association with rotavirus vaccination.
Autorzy :
Liles E; Kaiser Permanente Center for Health Research, 3800 North Interstate Avenue, Portland, OR 97227, United States. Electronic address: .
Irving SA; Kaiser Permanente Center for Health Research, 3800 North Interstate Avenue, Portland, OR 97227, United States. Electronic address: .
Dandamudi P; Kaiser Permanente Center for Health Research, 3800 North Interstate Avenue, Portland, OR 97227, United States. Electronic address: .
Belongia EA; Marshfield Clinic Research Institute, 1000 North Oak Avenue (ML2), Marshfield, WI 54449, United States. Electronic address: .
Daley MF; Kaiser Permanente of Colorado Institute for Health Research, 2550 South Parker Road, Suite 200, Aurora, CO 80014, United States. Electronic address: .
DeStefano F; Immunization Safety Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS V18-4, Atlanta, GA 30333, United States. Electronic address: .
Jackson LA; Kaiser Permanente Washington Health Research Institute, 1730 Minor Avenue, Suite 1600, Seattle, WA 98101, United States. Electronic address: .
Jacobsen SJ; Department of Research and Evaluation, Kaiser Permanente Southern California, 100 South Los Robles Avenue, Pasadena, CA 91101, United States.
Kharbanda E; HealthPartners Institute for Education and Research, 8170 33(rd) Avenue South, MS 23301A, Bloomington, MN 55425, United States. Electronic address: .
Klein NP; Vaccine Study Center, Kaiser Permanente Division of Research, 1 Kaiser Plaza, 16(th) Floor, Oakland, CA 94612, United States. Electronic address: .
Weintraub E; Immunization Safety Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS V18-4, Atlanta, GA 30333, United States. Electronic address: .
Naleway AL; Kaiser Permanente Center for Health Research, 3800 North Interstate Avenue, Portland, OR 97227, United States. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Jun 16; Vol. 39 (27), pp. 3614-3620. Date of Electronic Publication: 2021 May 26.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Gastric eosinophils are detrimental for Helicobacter pylori vaccine efficacy.
Autorzy :
Vaillant L; Service of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland.
Oster P; Service of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland.
McMillan B; Service of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland.
Velin D; Service of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Jun 16; Vol. 39 (27), pp. 3590-3601. Date of Electronic Publication: 2021 May 25.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Immunogenicity and persistence of high-dose recombinant hepatitis B vaccine in adults infected with human immunodeficiency virus in China: A randomized, double-blind, parallel controlled trial.
Autorzy :
Feng Y; School of Public Health, Shanxi Medical University, Taiyuan 030001, Shanxi, China; Center of Clinical Epidemiology and Evidence Based Medicine, Shanxi Medical University, Taiyuan 030001, Shanxi, China.
Yao T; School of Public Health, Shanxi Medical University, Taiyuan 030001, Shanxi, China; Center of Clinical Epidemiology and Evidence Based Medicine, Shanxi Medical University, Taiyuan 030001, Shanxi, China.
Chang Y; School of Public Health, Shanxi Medical University, Taiyuan 030001, Shanxi, China; Center of Clinical Epidemiology and Evidence Based Medicine, Shanxi Medical University, Taiyuan 030001, Shanxi, China.
Gao L; School of Public Health, Shanxi Medical University, Taiyuan 030001, Shanxi, China; Center of Clinical Epidemiology and Evidence Based Medicine, Shanxi Medical University, Taiyuan 030001, Shanxi, China.
Shao Z; School of Public Health, Shanxi Medical University, Taiyuan 030001, Shanxi, China.
Dong S; School of Public Health, Shanxi Medical University, Taiyuan 030001, Shanxi, China; Center of Clinical Epidemiology and Evidence Based Medicine, Shanxi Medical University, Taiyuan 030001, Shanxi, China.
Wu Y; School of Public Health, Shanxi Medical University, Taiyuan 030001, Shanxi, China; Center of Clinical Epidemiology and Evidence Based Medicine, Shanxi Medical University, Taiyuan 030001, Shanxi, China.
Shi X; School of Public Health, Shanxi Medical University, Taiyuan 030001, Shanxi, China; Center of Clinical Epidemiology and Evidence Based Medicine, Shanxi Medical University, Taiyuan 030001, Shanxi, China.
Shi J; School of Public Health, Shanxi Medical University, Taiyuan 030001, Shanxi, China; Center of Clinical Epidemiology and Evidence Based Medicine, Shanxi Medical University, Taiyuan 030001, Shanxi, China.
Feng D; School of Public Health, Shanxi Medical University, Taiyuan 030001, Shanxi, China.
Cheng Y; School of Public Health, Shanxi Medical University, Taiyuan 030001, Shanxi, China.
Pan M; School of Public Health, Shanxi Medical University, Taiyuan 030001, Shanxi, China.
Li C; School of Public Health, Shanxi Medical University, Taiyuan 030001, Shanxi, China.
Wang J; School of Public Health, Shanxi Medical University, Taiyuan 030001, Shanxi, China.
Lan G; Guangxi Center for Disease Control and Prevention, Nanning 530028, Guangxi Zhuang Autonomous Region, China.
Lu H; Guangxi Center for Disease Control and Prevention, Nanning 530028, Guangxi Zhuang Autonomous Region, China.
Wang P; Ningming Center for Disease Control and Prevention, Ningming 532500, Guangxi Zhuang Autonomous Region, China.
Xiang S; Ningming Center for Disease Control and Prevention, Ningming 532500, Guangxi Zhuang Autonomous Region, China.
Nong L; Ningming Center for Disease Control and Prevention, Ningming 532500, Guangxi Zhuang Autonomous Region, China.
Wang F; Chinese Center for Disease Control and Prevention, Beijing 100021, China.
Liang X; Chinese Preventive Medicine Association, Beijing 100021, China. Electronic address: .
Wang S; School of Public Health, Shanxi Medical University, Taiyuan 030001, Shanxi, China; Center of Clinical Epidemiology and Evidence Based Medicine, Shanxi Medical University, Taiyuan 030001, Shanxi, China. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Jun 16; Vol. 39 (27), pp. 3582-3589. Date of Electronic Publication: 2021 May 26.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Covid-19 vaccine trials: Ethnic diversity and immunogenicity.
Autorzy :
Jethwa H; Imperial College Healthcare NHS Trust, UK. Electronic address: .
Wong R; NIHR Clinical Research Network North West London, UK.
Abraham S; Imperial College Healthcare NHS Trust, UK.
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Jun 16; Vol. 39 (27), pp. 3541-3543. Date of Electronic Publication: 2021 May 11.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Lessons from the 1656 Neapolitan Plague: Something to learn for the current coronavirus Pandemic?
Autorzy :
Bifulco M; Department of Molecular Medicine and Medical Biotechnologies, University of Naples 'Federico II', Naples, Italy. Electronic address: .
Pisanti S; Department of Medicine, Surgery and Dentistry 'Scuola Medica Salernitana', University of Salerno, Salerno, Italy.
Fusco I; CNR-ISEM (Institute of History of Mediterranean Europe), Cagliari-Rome-Milan, Italy.
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Jun 16; Vol. 39 (27), pp. 3641-3643. Date of Electronic Publication: 2021 May 21.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Is further research on adult pneumococcal vaccine uptake improvement programs worthwhile? Α value of information analysis.
Autorzy :
Wateska AR; University of Pittsburgh, School of Medicine, Pittsburgh, PA, United States. Electronic address: .
Nowalk MP; University of Pittsburgh, School of Medicine, Pittsburgh, PA, United States. Electronic address: .
Jalal H; University of Pittsburgh, Graduate School of Public Health, Pittsburgh, PA, United States. Electronic address: .
Lin CJ; The Ohio State University College of Nursing, United States. Electronic address: .
Harrison LH; University of Pittsburgh, School of Medicine, Pittsburgh, PA, United States; University of Pittsburgh, Graduate School of Public Health, Pittsburgh, PA, United States. Electronic address: .
Schaffner W; Vanderbilt University School of Medicine, Nashville, TN, United States. Electronic address: .
Zimmerman RK; University of Pittsburgh, School of Medicine, Pittsburgh, PA, United States. Electronic address: .
Smith KJ; University of Pittsburgh, School of Medicine, Pittsburgh, PA, United States. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Jun 16; Vol. 39 (27), pp. 3608-3613. Date of Electronic Publication: 2021 May 25.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Prevalence and determinants of SARS-CoV-2 vaccine hesitancy in Hong Kong: A population-based survey.
Autorzy :
Luk TT; School of Nursing, The University of Hong Kong, Hong Kong Special Administrative Region. Electronic address: .
Zhao S; School of Nursing, The University of Hong Kong, Hong Kong Special Administrative Region. Electronic address: .
Wu Y; School of Nursing, The University of Hong Kong, Hong Kong Special Administrative Region. Electronic address: .
Wong JY; School of Nursing, The University of Hong Kong, Hong Kong Special Administrative Region. Electronic address: .
Wang MP; School of Nursing, The University of Hong Kong, Hong Kong Special Administrative Region. Electronic address: .
Lam TH; School of Public Health, The University of Hong Kong, Hong Kong Special Administrative Region. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Jun 16; Vol. 39 (27), pp. 3602-3607. Date of Electronic Publication: 2021 May 18.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Operational research for the safe and effective design of COVID-19 mass vaccination centres.
Autorzy :
Wood RM; Bristol, North Somerset and South Gloucestershire Clinical Commissioning Group, UK National Health Service, Bristol, UK; Centre for Healthcare Improvement and Innovation, School of Management, University of Bath, Bath, UK. Electronic address: .
Murch BJ; Bristol, North Somerset and South Gloucestershire Clinical Commissioning Group, UK National Health Service, Bristol, UK.
Moss SJ; Bristol, North Somerset and South Gloucestershire Clinical Commissioning Group, UK National Health Service, Bristol, UK.
Tyler JMB; Bristol, North Somerset and South Gloucestershire Clinical Commissioning Group, UK National Health Service, Bristol, UK.
Thompson AL; Institute for Risk and Disaster Reduction, University College London, London, UK.
Vasilakis C; Centre for Healthcare Improvement and Innovation, School of Management, University of Bath, Bath, UK.
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Jun 16; Vol. 39 (27), pp. 3537-3540. Date of Electronic Publication: 2021 May 14.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Feasibility assessment of measles and rubella eradication.
Autorzy :
Moss WJ; International Vaccine Access Center, Departments of Epidemiology and International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. Electronic address: .
Shendale S; Department of Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland.
Lindstrand A; Department of Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland.
O'Brien KL; Department of Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland.
Turner N; Division of General Practice and Primary Health Care, University of Auckland, Auckland, New Zealand.
Goodman T; Department of Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland.
Kretsinger K; Department of Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland.
Pokaż więcej
Corporate Authors :
SAGE Working Group on Measles and Rubella Vaccines
Measles and Rubella Eradication Feasibility Assessment Workshop Participants
Źródło :
Vaccine [Vaccine] 2021 Jun 16; Vol. 39 (27), pp. 3544-3559. Date of Electronic Publication: 2021 May 24.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Protective role of PhtD and its amino and carboxyl fragments against pneumococcal sepsis.
Autorzy :
André GO; Laboratório de Microbiologia Molecular e Clínica, Universidade São Francisco, Bragança Paulista, Brazil.
Borges MT; Laboratório de Microbiologia Molecular e Clínica, Universidade São Francisco, Bragança Paulista, Brazil.
Assoni L; Laboratório de Microbiologia Molecular e Clínica, Universidade São Francisco, Bragança Paulista, Brazil.
Ferraz LFC; Laboratório de Microbiologia Molecular e Clínica, Universidade São Francisco, Bragança Paulista, Brazil.
Sakshi P; College of Medicine and Public Health. Flinders University, Adelaide, South Australia, Australia.
Adamson P; Department of Microbiology and Infectious Diseases, Flinders University, Adelaide, South Australia, Australia.
Gordon DL; Department of Microbiology and Infectious Diseases, Flinders University, Adelaide, South Australia, Australia.
Ogunniyi AD; Australian Centre for Antimicrobial Resistance Ecology, School of Animal and Veterinary Sciences, The University of Adelaide, Roseworthy, South Australia, Australia.
Venter H; Health and Biomedical Innovation, Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia.
Converso TR; Laboratório de Microbiologia Molecular e Clínica, Universidade São Francisco, Bragança Paulista, Brazil.
Darrieux M; Laboratório de Microbiologia Molecular e Clínica, Universidade São Francisco, Bragança Paulista, Brazil. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Jun 16; Vol. 39 (27), pp. 3626-3632. Date of Electronic Publication: 2021 May 25.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Immunogenicity and safety of two monovalent rotavirus vaccines, ROTAVAC® and ROTAVAC 5D® in Zambian infants.
Autorzy :
Chilengi R; Centre for Infectious Disease Research in Zambia, Zambia.
Mwila-Kazimbaya K; Centre for Infectious Disease Research in Zambia, Zambia.
Chirwa M; Centre for Infectious Disease Research in Zambia, Zambia.
Sukwa N; Centre for Infectious Disease Research in Zambia, Zambia.
Chipeta C; Centre for Infectious Disease Research in Zambia, Zambia.
Velu RM; Centre for Infectious Disease Research in Zambia, Zambia.
Katanekwa N; Centre for Infectious Disease Research in Zambia, Zambia.
Babji S; The Wellcome Trust Research Laboratory, Vellore, India.
Kang G; The Wellcome Trust Research Laboratory, Vellore, India.
McNeal MM; Department of Pediatrics, University of Cincinnati College of Medicine, Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Meyer N; Department of Pediatrics, University of Cincinnati College of Medicine, Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Gompana G; PATH, India.
Hazra S; PATH, India.
Tang Y; PATH, USA.
Flores J; PATH, USA.
Bhat N; PATH, USA.
Rathi N; PATH, India. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Jun 16; Vol. 39 (27), pp. 3633-3640. Date of Electronic Publication: 2021 May 12.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Safety and immunogenicity of a seasonal quadrivalent influenza vaccine (GC3110A) in healthy participants aged ≥ 65 years.
Autorzy :
Kim TH; Division of Infectious Diseases, Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Republic of Korea.
Choi JH; Division of Infectious Diseases, Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. Electronic address: .
Park SH; Division of Infectious Diseases, Department of Internal Medicine, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Daejeon, Republic of Korea; Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Yoo JH; Division of Infectious Diseases, Department of Internal Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Republic of Korea; Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Lee DG; Division of Infectious Diseases, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Choi SM; Division of Infectious Diseases, Department of Internal Medicine, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Kim YR; Division of Infectious Diseases, Department of Internal Medicine, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Uijeongbu, Republic of Korea; Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Lee MS; Division of Infectious Diseases, Department of Internal Medicine, Kyung Hee University School of Medicine, Seoul, Republic of Korea.
Choo EJ; Division of Infectious Diseases, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Republic of Korea.
Choi HJ; Division of Infectious Diseases, Department of Internal Medicine, Ewha Womans University Mokdong Hospital, Ewha Womans University, Seoul, Republic of Korea.
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Jun 16; Vol. 39 (27), pp. 3621-3625. Date of Electronic Publication: 2021 May 13.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Older adults' vaccine hesitancy: Psychosocial factors associated with influenza, pneumococcal, and shingles vaccine uptake.
Autorzy :
Nicholls LAB; School of Psychological Sciences & Health, University of Strathclyde, 40 George Street, Glasgow G1 1QE, UK. Electronic address: .
Gallant AJ; School of Psychological Sciences & Health, University of Strathclyde, 40 George Street, Glasgow G1 1QE, UK.
Cogan N; School of Psychological Sciences & Health, University of Strathclyde, 40 George Street, Glasgow G1 1QE, UK.
Rasmussen S; School of Psychological Sciences & Health, University of Strathclyde, 40 George Street, Glasgow G1 1QE, UK.
Young D; Department of Mathematics and Statistics, University of Strathclyde, 26 Richmond Street, Glasgow G1 1XH, UK.
Williams L; School of Psychological Sciences & Health, University of Strathclyde, 40 George Street, Glasgow G1 1QE, UK.
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Jun 11; Vol. 39 (26), pp. 3520-3527. Date of Electronic Publication: 2021 May 20.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Strengthening and accelerating SARS-CoV-2 vaccine safety surveillance through registered pre-approval rollout after challenge tests.
Autorzy :
Eyal N; Center for Population-Level Bioethics and Department of Philosophy, Rutgers University, New Brunswick, NJ, USA, Department of Health Behavior, Society and Policy, Rutgers School of Public Health, Piscataway, NJ, USA; Rutgers Biomedical and Health Sciences, Newark, NJ, USA.
Gerhard T; Center for Pharmacoepidemiology and Treatment Science, Rutgers University, New Brunswick, NJ, USA, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ, USA; Rutgers Biomedical and Health Sciences, Newark, NJ, USA.
Strom BL; Rutgers Biomedical and Health Sciences, Newark, NJ, USA. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Jun 11; Vol. 39 (26), pp. 3455-3458. Date of Electronic Publication: 2021 Apr 30.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
COVID-19*
Viral Vaccines*
COVID-19 Vaccines ; Humans ; Prior Authorization ; SARS-CoV-2
Czasopismo naukowe
Tytuł :
Minimising missed opportunities to promote and deliver immunization services to middle and older age adults: Can hospital-based programs be a solution?
Autorzy :
McFadden K; School of Population Health, University of New South Wales, NSW, Australia.
Heywood A; School of Population Health, University of New South Wales, NSW, Australia.
Dyda A; School of Public Health, Faculty of Medicine, The University of Queensland, Herston, QLD, Australia.
Kaufman J; Murdoch Children's Research Institute, Melbourne, Australia; Royal Children's Hospital, Melbourne, Australia; University of Melbourne, Melbourne, Australia.
Seale H; School of Population Health, University of New South Wales, NSW, Australia. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Jun 11; Vol. 39 (26), pp. 3467-3472. Date of Electronic Publication: 2021 May 20.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
COVID-19*
Influenza Vaccines*
Adult ; Aged ; Australia ; COVID-19 Vaccines ; Cross-Sectional Studies ; Hospitals ; Humans ; Immunization ; Immunization Programs ; Middle Aged ; Pneumococcal Vaccines ; SARS-CoV-2 ; Vaccination
Czasopismo naukowe
Tytuł :
Patient and clinician factors associated with uptake of the human papillomavirus (HPV) vaccine among adolescent patients of a primary care network.
Autorzy :
Dang JHT; University of California, Davis School of Medicine, Division of Health Policy and Management, Department of Public Health Sciences, 4501 X Street, Suite 3003, Sacramento, CA 95817, USA. Electronic address: .
Stewart SL; University of California, Davis School of Medicine, Division of Biostatistics, Department of Public Health Sciences, 2450 48th Street, Suite 1600, Sacramento, CA 95817, USA.
Blumberg DA; University of California, Davis Health, Department of Pediatrics, 2561 Stockton Blvd, Sacramento, CA 95817, USA.
Rodriguez HP; University of California, Berkeley, School of Public Health, Division of Health Policy and Management, 2121 Berkeley Way #5427, Berkeley, CA 94704, USA.
Chen MS Jr; University of California, Davis School of Medicine, Division of Hematology and Oncology, 2540 48th Street, Suite 1600, Sacramento, CA 95817, USA.
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Jun 11; Vol. 39 (26), pp. 3528-3535. Date of Electronic Publication: 2021 May 19.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Older adolescents and young adults willingness to receive the COVID-19 vaccine: Implications for informing public health strategies.
Autorzy :
Afifi TO; Departments of Community Health Sciences and Psychiatry, University of Manitoba, Winnipeg, Canada. Electronic address: .
Salmon S; Department of Community Health Sciences, University of Manitoba, Winnipeg, Canada. Electronic address: .
Taillieu T; Instructor and Research Associate, Department of Community Health Sciences, University of Manitoba, Winnipeg, Canada. Electronic address: .
Stewart-Tufescu A; Faculty of Social Work, University of Manitoba, Winnipeg, Canada. Electronic address: .
Fortier J; Department of Community Health Sciences, University of Manitoba, Winnipeg, Canada. Electronic address: .
Driedger SM; Department of Community Health Sciences, University of Manitoba, Winnipeg, Canada. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Jun 11; Vol. 39 (26), pp. 3473-3479. Date of Electronic Publication: 2021 May 12.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19*
Vaccines*
Adolescent ; COVID-19 Vaccines ; Canada ; Female ; Humans ; Longitudinal Studies ; Male ; Manitoba ; Pandemics ; Public Health ; SARS-CoV-2 ; Vaccination ; Young Adult
Czasopismo naukowe
Tytuł :
PCV10 elicits Protein D IgG responses in Papua New Guinean children but has no impact on NTHi carriage in the first two years of life.
Autorzy :
Rahman T; Division of Paediatrics, University of Western Australia, Western Australia, Australia; Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Western Australia, Australia.
de Gier C; Division of Paediatrics, University of Western Australia, Western Australia, Australia; Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Western Australia, Australia.
Orami T; Papua New Guinea Institute of Medical Research, Goroka, Eastern Highlands Province, Papua New Guinea.
Seppanen EJ; Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Western Australia, Australia.
Granland CM; Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Western Australia, Australia.
Francis JP; Papua New Guinea Institute of Medical Research, Goroka, Eastern Highlands Province, Papua New Guinea.
Michael A; Papua New Guinea Institute of Medical Research, Goroka, Eastern Highlands Province, Papua New Guinea.
Yoannes M; Papua New Guinea Institute of Medical Research, Goroka, Eastern Highlands Province, Papua New Guinea.
Corscadden KJ; Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Western Australia, Australia.
Ford RL; Papua New Guinea Institute of Medical Research, Goroka, Eastern Highlands Province, Papua New Guinea.
Martinovich KM; Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Western Australia, Australia.
Jacoby P; Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Western Australia, Australia.
van den Biggelaar AHJ; Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Western Australia, Australia; Centre for Child Health Research, University of Western Australia, Perth, Australia.
Lehmann D; Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Western Australia, Australia; Centre for Child Health Research, University of Western Australia, Perth, Australia.
Richmond PC; Division of Paediatrics, University of Western Australia, Western Australia, Australia; Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Western Australia, Australia.
Pomat WS; Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Western Australia, Australia; Papua New Guinea Institute of Medical Research, Goroka, Eastern Highlands Province, Papua New Guinea.
Thornton RB; Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Western Australia, Australia; School of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Western Australia, Perth, Australia.
Kirkham LS; Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Western Australia, Australia; Centre for Child Health Research, University of Western Australia, Perth, Australia. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Jun 11; Vol. 39 (26), pp. 3486-3492. Date of Electronic Publication: 2021 May 21.
Typ publikacji :
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies